At the point when the eye experiences choroidal neovascularization, scar, or both, at the hour of treatment, the pace of repeat was 65% versus 33% if the concerned eye had no choroidal neovascularization, scar, or both. Normally a visual sharpness of four lines is lost when individual eyes had choroidal neovascularization, scar, or both, versus one line when the individual eye had no choroidal neovascularization or mark. Photocoagulation of choroidal neovascularization using LASER in patients experiencing angioid streaks can cause the ending of the choroidal neovascularization and adjustment of visual keenness. Treatment of choroidal neovascular membranes (CNVM) can differ depending on the concerned disease. Treatment consists of thermal laser treatment, anti-VEGF drugs, photodynamic therapy (PDT). Contingent upon the advancement of the illness, the individual may get at least one of these therapeutic treatment. Laser treatment is generally done as an outpatient strategy. It happens in the eye specialist's office or at the hospital. The LASER beam utilized in this treatment is a focused light having high energy.[5] It obliterates the abnormal blood veins, anticipating further spillage, dying, and development. After the laser treatment, vision may turn out to be more obscured than previously. Be that as it may, frequently it will balance out inside half a month. The treatment brings about a perpetual scar, making a lasting vulnerable side. This came about vulnerable sides, may be perceptible in the field of vision. Generally in the LASER treatment anomalous veins are demolished. In any case, patients regularly need re-treatment inside three to five years.
Combination treatment of low fluence photodynamic therapy and intravitreal ranibizumab for choroidal neovascular membrane secondary to angioid streaks in Paget′s disease - 12 month results
